Skip to main content

Polar Capital Healthcare Discovery Fund

Polar Capital Healthcare Discovery Fund is an equity fund managed by Polar Capital in the Sektor – Helse category.

About this fund

Polar Capital Healthcare Discovery Fund sits in the Sektor – Helse peer group, where Polar Capital is the manager.

The fund: 6 years of track record, running since 2020 (share classes may be younger).

It is run by a team of 4, led by Deane Donnigan.

It is measured against MSCI World Small Cap Health Care Net Total Return Index.

Manager
Polar Capital
Category
Sektor – Helse
Region
Global
SFDR
Article 8
ISIN
IE00BJXT2996
Inception
2020-01-31
Benchmark
MSCI World Small Cap Health Care Net Total Return Index
AUM
8 m USD
Returns
YTD 10.5% · 1Y 17.1% · 3Y 12.6% · 5Y 3.6%

Portfolio managers

Actively managedEquityGlobal
YTD Return · NOK
+10,5 %from NAV
The class started 31.01.2020. 10 years does not exist yet; the figure above is since launch, annualised (as of 30.10.2026).
Calculated NOK return from USD · USD Class I Acc (NOK Calculated)

Computed from NAV history (price return, NOK, to 13 Nov 2026)

Last NAV 17,16 USD · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+10,5 %
YTD
+17,1 %
1y
+12,6 %
3y, annualised
+3,6 %
5y, annualised
Fund size
8,1 mill. USD
Total fund AUM
Ongoing charge
1,11 %
Annual · class I
SFDR
Article 8
Sustainability
Launched
Jan 2020
ISIN IE00BJXT2996
BenchmarkMSCI World Small Cap Health Care · Net
About the fund
The fund

Polar Capital Healthcare Discovery Fund has a history going back to 2020. The management company, Polar Capital, is a specialist active manager in London, founded in 2001 and organised in relatively autonomous investment teams. The parent company is listed on AIM with a dispersed shareholder base.

Investment philosophy

The fund uses an index of small health care companies as its reference, and small and mid-sized companies form the core of the portfolio. Its active share is higher than that of comparable funds, and the ten largest positions make up a smaller share than in the team's broader healthcare funds.

The managers

Deane Donnigan is lead manager. She joined Polar Capital in 2013 and holds a doctorate in clinical pharmacy, is a licensed pharmacist and worked as a clinical specialist at Emory University Hospital. She later became an analyst and lead manager of healthcare and biotechnology funds at Framlington. She is part of Polar Capital's healthcare team in London, led by Gareth Powell, where David Pinniger and James Douglas are also listed on the fund. The managers also run other Polar Capital healthcare funds.

The portfolio

The lasting top positions are largely biotechnology and pharmaceutical companies such as Madrigal Pharmaceuticals and Xenon Pharmaceuticals, but also diagnostics, research equipment and health services, such as Guardant Health, Repligen and HealthEquity.

FundTelligence description · 18/10/2026

Portfolio managers

DE
Lead Manager
DA
Fund Manager
GA
Head of Healthcare
JA
Fund Manager

Position in the peer group

Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.

11 of 22 funds ranked on a calculated return

#4/ 221 year
+17.09% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#2/ 223 years (ann.)
+12.59% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#16/ 225 years (ann.)
+3.56% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

Comparison basis

1 year

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

3 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

5 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data